| http://www.w3.org/ns/prov#value | - EnteroMedics (NASDAQ:ETRM) earns a B this week, jumping up from last week???s grade of C. EnteroMedics is a development stage medical device company focused on the design and development of devices that use neuroblocking technology to treat obesity and other gastrointestinal disorders.
|
